The international normalized ratio overestimates coagulopathy in stable trauma and surgical patients

Journal of Trauma and Acute Care Surgery

Volumn 75, Issue 6, 2013, Pages 947-953

  McCully, Sean P ^a   Fabricant, Loic J ^a   Kunio, Nicholas R ^a   Groat, Tahnee L ^a   Watson, Katherine M ^a   Differding, Jerome A ^a   Deloughery, Thomas G ^b   Schreiber, Martin A ^a  

^a Trauma Research Institute of Oregon (TRIO)   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Coagulation; FFP transfusion; INR; TEG

Indexed keywords

BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; D DIMER; FIBRINOGEN; FRESH FROZEN PLASMA; PROTEIN C; PROTEIN S; PROTHROMBIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD CELL COUNT; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; BLOOD SAMPLING; FEMALE; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; SURGICAL PATIENT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD COAGULATION; BLOOD COAGULATION DISORDERS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; THROMBELASTOGRAPHY; WOUNDS AND INJURIES; YOUNG ADULT;

EID: 84890082585     PISSN: 21630755     EISSN: 21630763     Source Type: Journal    
DOI: 10.1097/TA.0b013e3182a9676c     Document Type: Article

References (30)

1. West KL, Adamson C, Hoffman M. ProphYlactic correction of the international normalized ratio in neurosurgery: A brief review of a brief literature. J Neurosurg. 2011;114:9-18.
2. Tripodi A, Caldwell SH, Hoffman M, Trotter JF, SanYal AJ. Reviewarticle: the prothrombin time test as a measure of bleeding risk and prognosis in liver disease. Aliment Pharmacol Ther. 2007;26:141-148.
3. Kamal AH, Tefferi A, Pruthi RK. How to interpret and pursue an abnormal prothrombin time, activated partial thromboplastin time, and bleeding time in adults. MaYo Clin Proc. 2007;82:864-873.
4. Stanworth SJ. The evidenceybased use of FFP and crYoprecipitate for abnormalities of coagulation tests and clinical coagulopathY. Hematology Am Soc Hematol Educ Program. 2007;179-186.
5. Carmassi F, De Negri F, Morale M, Ferrini L. Antithrombotic and antifibrinolytic effects of antithrombin 3 replacement in liver cirrhosis. Lancet. 1997;349:1069.
6. American SocietY of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Practice guidelines for perioperative blood transfusion and adjuvant therapies: an updated report bY the American SocietY of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. AnesthesiologY. 2006;105:198-208.
7. Segal JB, Dzik WH, Transfusion Medicine/Hemostasis Clinical Trials Network. PaucitY of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidencebased review. Transfusion. 2005;45:1413-1425.
8. O'ShaughnessY DF, AtterburY C, Bolton Maggs P, et al. Guidelines for the use of freshYfrozen plasma, crYoprecipitate and crYosupernatant. Br J Haematol. 2004;126:11-28.
9. Wallis JP, Dzik S. Is fresh frozen plasma overtransfused in the united states? Transfusion. 2004;44:1674-1675.
10. Blumberg N, Laczin J, McMican A, Heal J, Arvan D. A critical survey of freshYfrozen plasma use. Transfusion. 1986;26:511-513.
11. Jones HP, Jones J, Napier JA, alYIsmail S. Clinical use of FFP: results of a retrospective process and outcome audit. Transfus Med. 1998;8:37-41.
12. BrienWF, Butler RJ, Inwood MJ.An audit of blood component therapy in a Canadian general teaching hospital. CMAJ. 1989;140:812-815.
13. Thomson A,Contreras M,Knowles S.Blood component treatment:are trospective audit in five major London hospitals. J Clin Pathol. 1991;44:734-737.
14. Dara SI, Rana R, Afessa B, Moore SB, Gajic O. Fresh frozen plasma transfusion in criticallY ill medical patients with coagulopathY. Crit Care Med. 2005;33:2667-2671.
15. MacLennan S,Williamson LM. Risks of fresh frozen plasma and platelets. J Trauma. 2006;60:S46-S50.
16. Tinmouth A. Evidence for a rationale use of frozen plasma for the treatment and prevention of bleeding. Transfus Apher Sci. 2012;46:293-298.
17. McNicol PL, Liu G, HarleY ID, et al. Patterns of coagulopathy during liver transplantation: experience with the first 75 cases using thrombelastographY. Anaesth Intensive Care. 1994;22:659-665.
18. WelsbY IJ, Jiao K, Ortel TL, et al. The kaolinYactivated thrombelastograph predicts bleeding after cardiac surgery. J Cardiothorac Vasc Anesth. 2006;20:531-535.
19. Johansson PI. The blood bank: from provider to partner in treatment of massivelY bleeding patients. Transfusion. 2007;47:176S-181S; discussion 182S-183S.
20. Lier H, Vorweg M, Hanke A, Gorlinger K. ThromboelastometrY guided therapY of severe bleeding. Essener Runde algorithm. Hamostaseologie. 2013;33:51-61.
21. Anderson L, Quasim I, Soutar R, Steven M, Macfie A,KorteW. An audit of red cell and blood product use after the institution of thromboelastometrY in a cardiac intensive care unit. Transfus Med. 2006;16:31-39.
22. Spiess BD, Gillies BS, Chandler W, Verrier E. Changes in transfusion therapY and reexploration rate after institution of a blood management program in cardiac surgical patients. J Cardiothorac Vasc Anesth. 1995;9:168-173.
23. Shore-Lesserson L, Manspeizer HE, DePerio M, Francis S, Vela-Cantos F, Ergin MA. ThromboelastographYYguided transfusion algorithm reduces transfusions in complex cardiac surgerY. Anesth Analg. 1999;88:312-319.
24. Holland LL, Brooks JP. Toward rational fresh frozen plasma transfusion: the effect of plasma transfusion on coagulation test results. Am J Clin Pathol. 2006;126:133-139.
25. Abdel-Wahab OI, Healy B, Dzik WH. Effect of freshYfrozen plasma transfusion on prothrombin time and bleeding in patients with mild coagulation abnormalities. Transfusion. 2006;46:1279-1285.
26. Ciavarella D, Reed R, Counts R, Baron L, Pavlin E, Heimbach D. Clotting factor levels and the risk of diffuse microvascular bleeding in the massivelY transfused patient. Br J Haematol. 1987;67:365-368.
27. Deitcher SR. Interpretation of the international normalised ratio in patients with liver disease. Lancet. 2002;359:47-48.
28. Yuan S, Ferrell C, Chandler WL. Comparing the prothrombin time INR versus the APTT to evaluate the coagulopathy of acute trauma. Thromb Res. 2007;120:29-37.
29. Fisher NC, Mutimer DJ. Central venous cannulation in patients with liver disease and coagulopathy-a prospective audit. Intensive Care Med. 1999;25:481-485.
30. DeLoughery T, Liebler J, Simonds V, Goodnight S. Invasive line placement in criticallY ill patients: do hemostatic defects matter? Transfusion. 1996;36:827-831.